Join us for a unique two-day international symposium that brings together leading scientists, students and industry sponsors from across Europe to explore the latest advancements in pre-clinical radiation-oncology research. This event will feature in-depth sessions on cutting-edge topics, including pre-clinical radiotherapy, radiation biology, advanced imaging technologies and the growing role of artificial intelligence in this research field. Through dynamic discussions and collaborations, we aim to drive innovation and accelerate the translation of pre-clinical discoveries into clinical applications.
The symposium is organised by students of the PAIR project, an interdisciplinary FWF-funded PhD programme dedicated to bridging the knowledge gap in pre-clinical ion-beam research. Through five interconnected PhD projects, PAIR integrates physics, cancer biology and data science to explore the molecular, cellular and tissue-level effects of ion therapy.
Registration is free and open to students, researchers, and professionals across the scientific community. Don't miss this opportunity to participate. Submit your abstract for a chance to present your work through a short talk or poster session.
Abstract submission deadline: September 30th, 2025 Registration deadline: October 27th, 2025
The PAIR Symposium 2025 was a great success, and we extend our heartfelt gratitude to all attendees, speakers, and sponsors who made this event possible.
Relive the memories! All photos from the symposium are available for download.
View Photo Gallery →Note: The password to access the photo drive was sent to all registered attendees via email.
Having trouble accessing the photos? Contact us at pairsymposium2025@gmail.com
Oncology
Eric Deutsch, MD, PhD, is a Professor of Radiation Oncology, Vice-Dean for Research at Paris-Saclay University, and Head of the Radiation Oncology Department at Gustave Roussy Cancer Campus, Villejuif. He directs several innovative clinical trials focusing on radiotherapy combined with immunotherapy. Prof. Deutsch leads a preclinical research lab investigating radiobiology, immunotherapy, biomarkers, and radiomics. He is notably involved in translating research into clinical practice through projects known as RHU LYSAIRI. A recipient of numerous awards including the Claudius Regaud Prize, Prof. Deutsch actively contributes to international guidelines and standards in oncology.
Radiobiology
Udo Gaipl is the Head of Translational Radiobiology at the Radiation Oncology Department of the Universitätsklinikum Erlangen and currently the 1st Chairman of the German Society for Biological Radiation Research (DeGBS). The key research focus of his group is to understand immunological modes of action of radiation exposure ranging from radiation protection issues, over modulation of inflammation to tumor immunology. With translational research approaches they further aim to define predictive immune biomarkers for multimodal radio-immunotherapies, including combination of radiotherapy with immune checkpoint targeting, vaccination and hyperthermia.
Physics
Katia Parodi is since 2012 Full Professor and Founding Chair of Medical Physics at the Physics Faculty of the Ludwig-Maximilians-University in Munich. Here she initiated a dedicated curriculum for Medical Physics within the Physics MSc and started several lines of research in high-precision image-guided radiotherapy, with focus on advanced methods for delivery, imaging and in-vivo monitoring of pre-clinical and clinical ion beam therapy. Her scientific work is reported in over 300 publications in peer-reviewed journals, and she serves since 2021 as Editor-in-Chief of the journal Physics in Medicine and Biology.
Oncology
Erik Wennerberg is a tumour immunologist and Career Development Faculty in the Division of Radiotherapy and Imaging at the Institute of Cancer Research (ICR), London. He has a special interest in therapy-induced immune resistance mechanisms in cancer. His team focuses on identifying immunometabolic determinants of radiotherapy response and to develop treatment strategies that counter radiotherapy-induced immunometabolic checkpoints, including ART1 and other molecules involved in purinergic signalling.
View the draft schedule below or download the PDF ⬇.
Join us in the vibrant city of Vienna. The symposium will take place in the heart of the city, surrounded by its rich history and breathtaking architecture.
Dosimetric aspects of image-guided pre-clinical ion-beam research
Multiparametric MRI in pre-clinical research – medical-physics aspects
Pre-clinical data-science in ion-beam research
Biological effects of particle-beam therapy on pancreatic cancer
Harnessing particle radiation & small-molecule inhibitors in pancreatic cancer
For enquiries, email pairsymposium2025@gmail.com